Pharmaceutical

Filter

Current filters:

None

Popular Filters

51 to 75 of 7185 results

England's cancer outcomes worse than rest of Europe: National Audit Office report

England's cancer outcomes worse than rest of Europe: National Audit Office report

16-01-2015

The UK’s National Audit Office has published a report, Progress in improving cancer services and outcomes…

Markets & MarketingOncologyPharmaceuticalPoliticsPricingResearchUK

OncoGenex’ Ph III custirsen trial cleared to continue

16-01-2015

Canada’s OncoGenex Pharmaceuticals says that the AFFINITY trial is continuing as planned based upon…

custirsenOncoGenex PharmaceuticalsOncologyPharmaceuticalResearch

WuXi acquires NextCODE Health in $65 million cash deal

WuXi acquires NextCODE Health in $65 million cash deal

16-01-2015

Shanghai-headquartered pharmatech company WuXi has acquired NextCODE Health, a genomic analysis and bioinformatics…

ChinaMergers & AcquisitionsNextCODE HealthPharmaceuticalWuXi PharmaTech

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

16-01-2015

The European Commission has granted marketing authorizations for US drugmaker AbbVie’s all-oral, short-course,…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

16-01-2015

The Delaware Court of Chancery has entered its Final Order and Judgment in the case brought by US pharma…

Anti-viralsLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

16-01-2015

US specialty drugmaker Depomed has entered into a definitive agreement to acquire the US rights to the…

DepomedGrunenthalJanssenJohnson & JohnsonLicensingNeurologicalNucyntaPharmaceuticalUSA

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Baby boomers and BRICS will boost industry in 2015, report predicts

Baby boomers and BRICS will boost industry in 2015, report predicts

15-01-2015

The biggest trends in the health care industry in 2014 are expected to develop further in 2015, according…

GlobalHealthcareInternational relationsMarketResearch.comPharmaceutical

High turnover and protocol noncompliance continue to plague the global investigative site landscape, says Tufts CSDD

15-01-2015

Global clinical trial performance and efficiency are hampered by high turnover and noncompliance among…

ManagementPharmaceuticalResearchUSA

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

15-01-2015

The pharmaceutical industry faces a number of unique challenges when recruiting staff. Unlike in many…

BoardroomGlobalHireRightPharmaceuticalPharmacology

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

15-01-2015

Japanese drug major Astellas Pharma has appointed Eric Terhaerdt as senior vice president of global development…

AstellasAstellas PharmaBoardroomEric TerhaerdtJapanPharmaceutical

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

15-01-2015

French pharma major Sanofi has entered into a strategic agreement with German family-owned peer Boehringer…

Boehringer IngelheimGermanyLicensingPharmaceuticalResearchSanofi

2014 a memorable year for M&A activity in pharma sector

2014 a memorable year for M&A activity in pharma sector

15-01-2015

2014 was a busy year for merger and acquisition activity in the pharmaceutical industry, but will be…

GlobalMergers & AcquisitionsPfizerPharmaceuticalShire

Regado and Tobira to merge to create leading NASH company

Regado and Tobira to merge to create leading NASH company

14-01-2015

The USA’s Regado Biosciences and privately-held Tobira Therapeutics have entered into a definitive…

Mergers & AcquisitionsNephrology and HepatologyPharmaceuticalRegadoTobira TherapeuticsUSA

Boehringer opts to take up rights to Oxford BioThera’s oncology target

Boehringer opts to take up rights to Oxford BioThera’s oncology target

14-01-2015

Privately-held, UK-based Oxford BioTherapeutics says that German family-owned pharma major Boehringer…

Boehringer IngelheimLicensingOncologyOxford BioTherapeuticsPharmaceuticalUK

Health care and pharma execs optimistic about business conditions in 2015: Economist report

Health care and pharma execs optimistic about business conditions in 2015: Economist report

14-01-2015

More than half of pharma and healt care executives expect business conditions for their company to improve…

GlobalMarkets & MarketingPharmaceuticalPricingProductionResearch

Report: Denmark’s pharma market expected to drop to $3 billion by 2020

Report: Denmark’s pharma market expected to drop to $3 billion by 2020

14-01-2015

Denmark’s pharmaceutical market will decline in value from $3.5 billion in 2013 to $3 billion by 2020,…

DenmarkFinancialMarkets & MarketingPharmaceuticalPricing

Boehringer Ingelheim enters research pact with Yale University

Boehringer Ingelheim enters research pact with Yale University

14-01-2015

German family-owned pharma major Boehringer Ingelheim has entered into a collaboration with Yale University,…

Boehringer IngelheimGermanyImmunologicalsOncologyPharmaceuticalResearchRespiratory and Pulmonary

ORCHID project aims to slash development time of tuberculosis drugs

ORCHID project aims to slash development time of tuberculosis drugs

14-01-2015

A collaborative project led by a scientist from UK pharma major GlaxoSmithKline has identified new compounds…

Antibiotics and Infectious diseasesGSKIsoniazidPharmaceuticalResearch

51 to 75 of 7185 results

Back to top